Showing results (551-560 of 1,120) with videos related to

Sort By:
Pageof 112
Arquivos Brasileiros De Cardiologia|March 9, 2022
Rationale and Design of the COVID-19 Outpatient Prevention Evaluation (COPE - Coalition V) Randomized Clinical Trial: Hydroxychloroquine vs. Placebo in Non-Hospitalized PatientsHaliton Alves de Oliveira Junior, Cleusa P Ferri, Icaro Boszczowski, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 28, 2019
Zika and Chikungunya Virus and Risk for Venous ThromboembolismEduardo Ramacciotti, Leandro B Agati, Valéria C R Aguiar, et al.
Plos Neglected Tropical Diseases|May 10, 2014
In vitro and in vivo trypanocidal activity of H2bdtc-loaded solid lipid nanoparticlesZumira A Carneiro, Pedro I da S Maia, Renata Sesti-Costa, et al.
Oxidative Medicine and Cellular Longevity|September 5, 2019
Combined Exercise Training Performed by Elderly Women Reduces Redox Indexes and Proinflammatory Cytokines Related to AtherogenesisAndré L L Bachi, Marcelo P Barros, Rodolfo P Vieira, et al.
BMJ (Clinical Research Ed.)|June 17, 2016
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trialJeroen Jaspers Focks, Marc A Brouwer, Daniel M Wojdyla, et al.
European Journal of Medicinal Chemistry|August 21, 2018
β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove bindersMiguel M Vaidergorn, Zumira A Carneiro, Carla D Lopes, et al.
Circulation|June 7, 2018
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial FibrillationAbhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.
European Heart Journal|October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk scoreZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Marine Pollution Bulletin|October 31, 2025
Comprehensive review of polycyclic aromatic hydrocarbons (PAHs) in biota: Analytical methods and associated health and ecological risks in oiled and non-oiled areasAntônia D F Lima, Davi A Martins, Íthala S de Santiago, et al.
American Heart Journal|September 11, 2013
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDavid A Garcia, Lars Wallentin, Renato D Lopes, et al.
Pageof 112